May 11, 2026 06:25AM
May 7, 2026 08:00AM
May 7, 2026 08:00AM
Mar 3, 2026 08:00AM
Feb 26, 2026 06:00AM
Oct 30, 2025 04:16PM
Oct 30, 2025 04:15PM Certara Expands Biosimulation Market with AI-Driven QSP Platform
Oct 20, 2025 08:00AM
Sep 4, 2025 08:00AM
Jul 3, 2025 07:39AM
May 8, 2025 06:03AM
May 5, 2025 04:15PM
Apr 14, 2025 08:16AM
Apr 14, 2025 08:15AM Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing
Apr 1, 2025 08:00AM
Apr 1, 2025 08:00AM
Apr 1, 2025 08:00AM
Dec 2, 2024 04:15PM
Sep 24, 2024 08:00AM
Sep 18, 2024 08:00AM
Sep 18, 2024 08:00AM Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug
Aug 15, 2024 04:15PM
Aug 15, 2024 04:15PM
Nov 21, 2023 04:30PM
Nov 21, 2023 04:30PM
Nov 21, 2023 04:30PM
Sep 19, 2023 08:15AM
Aug 29, 2023 08:15AM Certara, Inc. (CERT) Awarded Two New Grants from US FDA
Aug 29, 2023 08:15AM
Aug 3, 2023 09:00PM
Apr 27, 2023 08:00AM
Apr 27, 2023 08:00AM
Mar 21, 2023 08:00AM
Mar 7, 2023 08:00AM
Mar 7, 2023 08:00AM Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types
Aug 5, 2022 08:00AM
Aug 5, 2022 08:00AM
Jun 28, 2022 08:00AM
Jun 28, 2022 08:00AM
Jun 21, 2022 08:00AM
Feb 23, 2022 04:31PM
Feb 23, 2022 04:30PM U.S. FDA Licenses Certara’s Immunogenicity Simulator
Feb 23, 2022 04:30PM
Feb 15, 2022 04:30PM
Feb 15, 2022 04:30PM
Dec 21, 2021 08:02AM
Dec 21, 2021 08:00AM
Dec 21, 2021 08:00AM
Dec 13, 2021 08:00AM Certara Announces Release of Pinnacle 21 Enterprise Software
Dec 13, 2021 08:00AM

322,088 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All